Evidence map›Paper›PMID 40061588›Full record

ArticleWorld journal of gastroenterology2025

Machine learning-based models for advanced fibrosis in non-alcoholic steatohepatitis patients: A cohort study.

Fei-Xiang Xiong, Lei Sun, Xue-Jie Zhang, Jia-Liang Chen, Yang Zhou, Xiao-Min Ji, Pei-Pei Meng, Tong Wu, Xian-Bo Wang, Yi-Xin Hou

Abstract read
In one paragraph

Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fei-Xiang XiongCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Lei SunCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Xue-Jie ZhangCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Jia-Liang ChenCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Yang ZhouCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Xiao-Min JiCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Pei-Pei MengCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Tong WuCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Xian-Bo WangCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Yi-Xin HouCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China. xuexin162@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe global prevalence of non-alcoholic steatohepatitis (NASH) and its associated risk of adverse outcomes, particularly in patients with advanced liver fibrosis, underscores the importance of early and accurate diagnosis.

aimTo develop a machine learning-based diagnostic model for advanced liver fibrosis in NASH patients.

methodsA total of 749 patients who underwent liver biopsy at Beijing Ditan Hospital, Capital Medical University, between January 2010 and January 2020 were included. Patients were randomly divided into training (

resultsThe Extreme Gradient Boosting (XGBoost) model outperformed all other machine learning models, achieving an AUROC of 0.934 (95%CI: 0.914-0.955) in the training cohort and 0.917 (95%CI: 0.880-0.953) in the validation cohort (

conclusionThe XGBoost model provides a highly accurate, non-invasive diagnosis of advanced liver fibrosis in NASH patients, outperforming traditional methods. An online tool based on this model has been developed to assist clinicians in evaluating the risk of advanced liver fibrosis.

Indexed as

Liver CirrhosisMachine LearningNon-alcoholic Fatty Liver DiseaseAdultAspartate AminotransferasesBiopsyCohort StudiesFemaleHumansLiverMaleMiddle AgedRetrospective StudiesROC CurveSeverity of Illness IndexAspartate AminotransferasesAdvanced fibrosisExtreme Gradient BoostingMachine learningNon-alcoholic steatohepatitisNon-invasive

Identifiers

PMID40061588
PMCPMC11886044

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.